Moreover, Gao et al. (2011) have shown that dopaminergic neurodegeneration in experimental Parkinson Disease requires HMGB-1-activated microglia and downstream NF-κB signaling (Gao et al., 2011). Here, NFKB1 is linked to Parkinson disease.